Skip to content

Operating Income at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$93M-75.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$34.1M+43.9%
Revvity logo
RevvityRVTY
$75.89M+5.1%
Danaher logo
DanaherDHR
$1.34B+5.5%
Repligen logo
RepligenRGEN
$15.94M+142%
BioLife Solutions logo
BioLife SolutionsBLFS
$27K+105%

Segments

By segment

See full
Life Sciences Solutions$954M+14.4%
Laboratory Products and Biopharma Services$778M+6.4%
Analytical Instruments$355M-11.0%
Specialty Diagnostics$313M+3.0%

Other financials

Income statement

See full
Revenue$11.0B+6.2%
Net income$1.7B+9.6%
EPS (diluted)$4.43+11.3%

Balance sheet

See full
Cash & equivalents$3.3B-21.4%
Total debt$43.2B+16.6%
Total equity$51.9B+5.2%
Total assets$113.28B+14.4%

Cash flow

See full
Operating cash flow$1.2B+64.9%
CapEx$376.0M+3.9%
Free cash flow$816.0M+126%

Valuation

See full
Market cap$187.95B+25.1%
Enterprise value$227.83B+24.5%
P/E27.5×+4.4×
P/S4.3×-0.8×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%-0.2pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.2×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's operating income?
Thermo Fisher Scientific (TMO) reported operating income of $1.86B in Q1 2026.
How has Thermo Fisher Scientific's operating income changed year-over-year?
Thermo Fisher Scientific's operating income increased by 8.6% year-over-year, from $1.72B to $1.86B.
What is the long-term trend for Thermo Fisher Scientific's operating income?
Over 3 years (2021 to 2024), Thermo Fisher Scientific's operating income has grown at a -9.9% compound annual growth rate (CAGR), from $10.03B to $7.34B.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.